Please use this product under the supervision of a trained practitioner
RestorFlora is a probiotic supplement that combines well-studied and widely-used probiotic strains Saccharomyces Boulardii, Bacillus Subtilis HU58, and Bacillus Clausii. This combination of probiotic yeast and bacteria offers comprehensive digestive flora support with an advanced, dual-action approach to maintain a healthy intestinal environment.
What is RestorFlora?
RestorFlora is the first probiotic bacteriotherapy product that has combined three of the world’s most well studied and widely used probiotic strains – Saccharomyces Boulardii, Bacillus Subtilis HU58 and Bacillus Clausii. This combination of clinically studied, friendly probiotic yeast and probiotic bacteria offer comprehensive digestive flora support with an advanced, dual-action approach to maintain a healthy intestinal environment.
Saccharomyces boulardii is well studied and extensively used for its ability to curb digestive issues associated with antibiotic use. However, a product containing only S. boulardii has limitations with regards to other probiotic functions. RestorFlora represents a significant advancement that overcomes these limitations with the addition of Bacillus Subtilis HU58 and Bacillus Clausii. RestorFlora provides competitive exclusion of bad and potentially harmful organisms, as well as the ability to colonize in the digestive tract to produce favourable immune responses.
Benefits of RestorFlora
- Supports a balanced intestinal flora
- Promotes intestinal health
- Supports healthy bowel movement
- Aids in digestion
- Detoxifies the intestinal tract
- Supports healthy immune function
- Maintains regularity
Competitive Exclusion of Pathogenic and Potentially Harmful Organisms
Antibiotic use, daily stresses, poor diets, chemicals, age, fluoride exposure, etc. makes the digestive system susceptible to pathogenic bacteria and yeast overgrowth. RestorFlora is formulated with Bacillus Subtilis HU58 and Bacillus Clausii; both species have been shown to be potent competitive exclusions probiotics and widely used as a protective probiotic for nearly 60 years in the pharmaceutical industry in Europe and Asia.
Ability to Colonize the Digestive Tract and Produce Favorable Immune Changes
Both bacillus species found in RestorFlora have been demonstrated to favour an anti-inflammatory reaction in the digestive tract. Inflammation in the digestive system is at the root of many disorders both systemically and intestinal.
Improves Energy and Helps to Maintain Blood Glucose Levels
Cellular energy output is largely controlled by digestive health. Studies have demonstrated that the short-chain fatty acids produced by RestorFlora help to maintain a healthy fasting blood glucose, fasting insulin and insulin tolerance, which improves sugar metabolism, so you get a better balance of energy from fat and sugars.
1-2 capsule per day with a meal, or as directed by your physician. Capsules may be opened to sprinkle contents on soft foods, water, juice, or other non-carbonated beverages for easy consumption.
*THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THESE PRODUCTS ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.
SAMANYA M, YAMAUCHI K.
Histological alterations of intestinal villi in chickens fed dried Bacillus subtilis var. natto. Comp Biochem Physiol A Mol Integr Physiol. 2002;133(1):95-104.
NISTA EC, CANDELLI M, CREMONINI F, ET AL.
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 2004 Nov;20(10):1181-8.
CZERUCKA D, DAHAN S, MOGRABI B, ET AL.
Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun. 2000 Oct;68(10):5998-6004.
TAM NKM, UYEN NQ, HONG HA, ET AL.
The Intestinal Life Cycle of Bacillus subtilis and Close Relatives. Journal of Bacteriology. 2006;188(7):2692-2700.
GABRIELLI M, LAURITANO EC, SCARPELLINI E, ET AL.
Bacillus clausii as a Treatment of Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2009;104(5):1327-8.
SOUGIOULTZIS S, SIMEONIDIS S, BHASKAR KR, ET AL.
Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun. 2006 Apr 28;343(1):69-76.
MARSEGLIA GL, TOSCA M, CIRILLO I, ET AL.
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study. Ther Clin Risk Manag. 2007;3(1):13-7.
DI CARO S, TAO H, GRILLO A, ET AL.
Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur J Gastroenterol Hepatol. 2005;17(9):951-60.
GONG Y, LI H, LI Y.
Effects of Bacillus subtilis on epithelial tight junctions of mice with inflammatory bowel disease. J Interferon Cytokine Res. 2016;36(2).
URDACI MC, BRESSOLLIER P, PINCHUK I, ET AL.
Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities. J Clin Gastroenterol. 2004;38(6 Suppl): S86-90.
CIPRANDI G, TOSCA MA, MILANESE M, ET AL.
Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: A pilot study. Pediatr Allergy Immunol. 2004;15(2):148-51.